Skip to main content
Infectious Disease Modelling logoLink to Infectious Disease Modelling
. 2020 Jul 22;5:525–535. doi: 10.1016/j.idm.2020.07.002

Sensitivity of UK Covid-19 deaths to the timing of suppression measures and their relaxation

John S Dagpunar 1
PMCID: PMC7373688  PMID: 32835143

Abstract

In this paper I examine the sensitivity of total UK Covid-19 deaths and the demand for intensive care and ward beds, to the timing and duration of suppression periods during a 500- day period. This is achieved via a SEIR model. Using an expected latent period of 4.5 days and infectious period of 3.8 days, R0 was first estimated as 3.18 using observed death rates under unmitigated spread and then under the effects of the total lockdown (R0=0.60) beginning 23 March. The case fatality rate given infection is taken as 1%. Parameter values for mean length of stay and conditional probability of death for ICU and non-ICU hospital admissions are guided by Ferguson et al. (2020). Under unmitigated spread the model predicts around 600,000 deaths in the UK. Starting with one exposed person at time zero and a suppression consistent with an R0 of 0.60 on day 72, the model predicts around 39,000 deaths for a first wave, but this reduces to around 11,000 if the intervention takes place one week earlier. If the initial suppression were in place until day 200 and then relaxed to an R0 of 1.5 between days 200 and 300, to be followed by a return to an R0 of 0.60, the model predicts around 43,000 deaths. This would increase to around 64,000 if the release from the first suppression takes place 20 days earlier. The results indicate the extreme sensitivity to timing and the consequences of even small delays to suppression and premature relaxation of such measures.

Keywords: Covid-19, SEIR model, Lockdown, Suppression, Halving time, Doubling time

1. The SEIR model

In order to model the spread of total Covid-19 deaths in the UK over the next 500 days say, one can build a detailed stochastic microsimulation model that includes spatial and age heterogeneity as in Davies et al. (2020) and Ferguson et al. (2020). In order to gain some understanding of the sensitivity with respect to the timing of suppression measures and their relaxation, a simple deterministic SEIR model, see for example Hethcote (2000) and Blackwood and Childs (2018), can be useful. That is the approach used in this paper. SEIR is a compartment based model with transitions as shown in Diagram 1. S stands for the number of susceptibles, those who have not yet been infected. Initially, almost the entire population is in that category. E is the number who are currently exposed, that is they are infected but not yet infectious. After a latent period, an exposed person becomes infectious and is able to infect susceptible persons. I is the number who are currently infectious. Initially, both I and E are small numbers in comparison to N, the population size. Each infectious person remains so for an infectious period. An infective person is one who is either exposed or infectious. Finally, R stands for those who are removed in the sense they have either recovered or died. In the simple form of the model considered here it is assumed that S+E+I+R=N. The SEIR model is more appropriate than a SIR model for Covid-19 as SIR does not separate the exposed and infectious states.

Diagram 1.

Diagram 1

SEIR compartments.

A key controllable parameter is the reproduction number R0 which is the expected number of susceptibles that an infector will infect, when the susceptible proportion is close to 1. It is thought that a significant proportion of those infected may be asymptomatic or pre-symptomatic, see for example He et al. (2020), in which case they might spend all or part of the infectious period unknowingly infecting susceptibles, although there is a question as to how much virus they shed. On the other hand, those who are symptomatic may spend some of that time in self-isolation which reduces the R0 for them. One of the simplifying assumptions of the model developed here is that people can transmit the virus throughout their infectious period. Micro simulation models allow such an assumption to be relaxed. They can also track evolution through multiple transmission routes on a network, as modelled for example by Zhao et al. (2014).

A person will transition between these compartments. The SEIR model will keep track of how many are in each compartment by noting the rate at which people join and leave a compartment. The key dynamic element of this process is the transmission rate β at which an infectious person infects susceptibles.

Diagram 1 shows the rates of movement between the compartments. The mean latent and infectious periods are respectively 1μ and 1σ , while pH is the probability that an infectious person is admitted to hospital. R3 is the cumulative number who do not require hospital treatment. It is assumed that all such persons survive, but it may be more accurate to say with hindsight that it may include an appreciable number of people in the community who never went to hospital and did not survive. In that sense the model underestimates the cumulative number of deaths. The model is an idealisation of what happens in practice as some people will enter hospital while still infectious and some will self-isolate during the infectious state. This can be compensated for by a suitable choice of σ.

2. Bed occupancy

Apart from predicting the number of deaths it is also important to predict the demand for ward and intensive care beds. The UK National Health Service (NHS) has approximately 150,000 ward beds and around 4200 intensive care beds. Clearly, one could not expect to access all of these as the occupancy rate is high in normal times. There is the option of building surge capacity. Ideally, that would need to be matched by similar increases in medical, nursing, and ancillary staff; equipment such as ventilators; personal protective equipment; and testing for presence of the virus, all of which have become major issues. Turning now to what happens in hospitals, Diagram 2 gives a schematic view with the transition rates.

Diagram 2.

Diagram 2

Hospitalisation compartments.

An infectious person will move with probability pH to hospital. Of these a proportion p1 will never require an intensive care bed and will occupy a ward bed. Of those a proportion r1 will die and the rest will recover. Either way their average length of stay will be 1γ days. The remaining proportion 1p1 will spend an average of 1α days in a ward bed followed by an average of 1κ days in intensive care. A proportion r2 of those entering intensive care will die. For simplicity, those who recover are not re-directed to a ward bed. The symbol in each compartment gives the number of persons currently occupying it, D1 and D2 being the cumulative number of deaths from non-ICU and ICU patients respectively.

3. The dynamics

Diagram 1, Diagram 2 lead directly to differential equations (1), (2), (3), (4), (5), (6), (7), (8)

dSdt=βSIN (1)
dEdt=μE+βSIN (2)
dIdt=μEσI (3)
dW1dt=pHp1σIγW1 (4)
dD1dt=r1γW1 (5)
dW2dt=pH(1p1)σIαW2 (6)
dCdt=αW2κC (7)
dD2dt=r2κC (8)

4. Epidemic growth and decline rate in early stages

In this section we obtain the important results for the case when S/N1 . Equations (2), (3) can be written as

ddt(EI)=J(EI) (9)

where J=μβμσ. The eigenvalues of J are

λ=(σ+μ)±(σμ)2+4μβ2 (10)

The negative root will give a solution that decays rapidly and can be ignored, see for example Ma (2020). So, while the susceptible proportion is close to 1 we have the solution

E(t)=E(0)eλt (11)

and

I(t)=I(0)eλt (12)

where

λ=(σ+μ)+(σμ)2+4μβ2 (13)

that is

(λ+σ)(λ+μ)=βμ (14)

The expected number of secondary infections from one infectious person is

R0=βσ (15)

For the special case of σ=μ

λ=(R01)σ (16)

Substituting (10) into (9)

R0=(λ+σ)(λ+μ)μσ (17)

While λ>0 the doubling time is

ln(2)λ (18)

and when λ<0 the half-life (halving time) is

ln(2)λ (19)

5. Estimation of R0

From (11) and (12), in the early stages of the epidemic, current infectious numbers I(t), new daily infectious numbers μE(t), and daily deaths d(D1(t)+D2(t))dt, will all 1 change at rate λ so one could use any of these to estimate λ. In the UK there was a large proportion of infectious persons (including asymptomatic and pre-symptomatic) who were never tested 2 and the availability of tests changed markedly over time. Therefore, it is felt that the number of positive test results is not a reliable proxy for the number of infectious persons.

For this reason, λ was estimated by fitting the logarithm of daily deaths non-parametrically in the period 11 March to 2 April. The dates were selected as to be largely uninfluenced by the gentle suppression introduced on 16 March and the full lockdown beginning 23 March, given that there is a lag between exposure and death of the order of 22 days. The fit gave λ=0.189, 95% confidence interval (0.172, 0.206) with the amount explained by the regression as R2=0.96. The estimated doubling time in the early stages of unmitigated spread is ln(2)0.189 = 3.7 days.

In order to estimate R0 using (18) we need not only λ, but estimates of mean latent and infectious periods. Ferguson et al. (2020) assumed an incubation period of 5.1 days with a 12 h pre-symptomatic infectious period for some, together with a 6.5 day mean generation interval. Anderson et al. (2020, pp931) thought the incubation period to be around 5–6 days with a serial interval of similar duration. Using 181 confirmed cases outside Hubei province, Lauer et al. (2020) fitted a log normal incubation period with median 5.1 days. Li, Guan, et al. (2020) estimated a mean incubation period of 5.2 days, while Davies et al. (2020) assumed a gamma distributed latent period with mean and standard deviation of 4 and 2 days respectively, a mean incubation period of 5.5 days, and a serial interval of 6.5 days. Backer et al. (2020) estimated mean incubation period as 6.4 days. Li, Yang, et al. (2020) found that a mean incubation period of 6 days best fitted observed epidemic curves. Ganyani et al. (2020) estimated mean generation time to be 5.2 and 3.95 days respectively for Singapore and Tianjin data while Nishiura et al. (2020) estimated a Weibull serial interval with mean and standard deviation of 4.8 and 2.3 days based upon 18 certain infector-infectee pairs. Based upon 77 such pairs He et al. (2020) estimated a mean serial interval of 5.8 days.

In this paper we take the mean latent and infectious period to be 4.5 and 3.8 days respectively, leading to a crude estimate of the serial interval to be 4.5 + 0.5x3.8 = 6.4 days. Using these in (17) gives R0=3.18. The death data was that pertaining to English hospital deaths by date of death.3 This data set was chosen as many other accessible sets are by date of recording the death which can be several days after actual death. We assumed that the growth/decline rate λ is similar in all four countries of the UK. The model assumes all deaths occur in hospital and applies to the entire UK population of 67 million. For illustrative purposes this is considered reasonable although in the event many deaths occurred in the community including care homes. The model calculates bed occupancy assuming an ideal scenario where all who need hospital care receive it.

It is assumed that 1% of those infected die and 4.4% of those infected require hospital treatment. Of these 70% will never require intensive care and spend an average of 8 days in a ward bed. Of these 11% will die. Of the remaining 30%, all will spend 6 days in a ward followed by 10 days in intensive care and 50% of these will die. These parameter values give a case fatality rate given infection of 1%. These figures are adapted from those of Ferguson et al. (2020) and imply a mean of 21.6 days between exposure and death, similar to the 22.9 days of Flaxman et al. (2020).

6. Unmitigated spread

Table 1 summarises the model results over a period of 500 days with an initial condition of one exposed person at time zero and R0=3.18. Fig. 1 shows the death rate, required ward and intensive care beds, numbers of susceptible, exposed, and infectious, and cumulative deaths over time. Of note is the great speed at which the disease spreads, with almost all deaths occurring within 70 days. Secondly, is the fact that at the peak of the wave, the capacity of the health service, even assuming it was exclusively available to Covid-19 patients, is exceeded by a factor of around 50 and 4 for intensive care and ward beds respectively.

Table 1.

Summary model results for unmitigated spread.

Cumulative Deaths Final Susceptible Proportion Peak death rate (Day) Peak Ward beds (Day) Peak ICU beds (Day)
638,000 4.8% 18,000 (106) 685,000 (103) 232,000 (109)

Fig. 1.

Fig. 1

Unmitigated spread for UK.

7. An example suppression

Next I consider the effect of a lockdown such as the one implemented on 23 March 2020. I use death data for the period 15 to 30 April to estimate λ=0.054, with 95% confidence interval (−0.058, −0.050) and an explanatory R2 of 0.96. Thus, the estimated half-life in declining the peak, once the effect of the previous R0 of 3.18 has been largely eliminated, is ln(2)0.0539 = 12.9 days. Using (17) this gives a reproduction number of R0=0.60. It is relevant to note that this is quite close to the value of 0.62 arrived at by Jarvis et al. (2020) from a behavioural survey of people’s distancing following lockdown. Table 2 shows summary statistics and Fig. 2 the associated graphs.

Table 2.

R0=3.18 in (0, 72), R0=0.60 in (72, 500).

Cumulative Deaths Final Susceptible Proportion Peak death rate (Day) Peak Ward beds (Day) Peak ICU beds (Day)
39,000 94% 930 (88) 36,000 (82) 12,000 (92)

Fig. 2.

Fig. 2

Suppression to R0=0.60 on day 72.

Of note is the speed at which peak death rate is reached, some 16 days after starting suppression. We note that ICU capacity is exceeded by a factor of 3, while ward bed demand is approximately 25% of capacity.

8. The effect of an earlier suppression

Now suppose that the suppression in Table 2 takes place one week earlier on day 65. Table 3 and Fig. 3 show the model results. We see a very large reduction in absolute death numbers from around 39,000 to 11,000, This extreme sensitivity is a result of the exponential rise in infectious numbers and clearly illustrates that earlier action was needed and would have saved many lives. The peak death rate occurs 16 days after the beginning of suppression.

Table 3.

R0=3.18 in (0, 65), R0=0.60 in (65, 500).

Cumulative Deaths Final Susceptible Proportion Peak death rate (Day) Peak Ward beds (Day) Peak ICU beds (Day)
11,200 98% 260 (81) 9950 (74) 3350 (84)

Fig. 3.

Fig. 3

Suppression starts one week earlier.

9. Releasing the suppression to a relaxed R0 of 1.5

A lockdown to an R0 of 0.60 from day 72 to day 500 is unrealistic as it causes great economic and societal damage as well as increasing other mortality and morbidity. Now suppose that the suppression of Fig. 2 is released to a more relaxed R0 of 1.5 between days 200 and 300. That will mean there is a second wave so we limit its effect by suppressing again to R0 of 0.60 between days 300 and 500. The results are shown in Table 4 and Fig. 4.

Table 4.

R0=3.18 in (0, 72), R0=0.60 in (72, 200), R0=1.5 in (200, 300), R0=0.60 in (300, 500).

Cumulative Deaths Final Susceptible Proportion Peak death rate (Day) Peak Ward beds (Day) Peak ICU beds (Day)
42,800 94% 950 (88) 36,500 (82) 12,200 (91)

Fig. 4.

Fig. 4

Release and second suppression.

The total deaths have been limited to around 43,000 by driving down infectious numbers to very low levels in the first wave. The first suppression was released on day 200.

10. Effect of early release

What happens if the release from the first suppression is brought forward from day 200 to day 180? Table 5 and Fig. 5 show the results. The number of deaths has now increased by around 20,000 an increase of approximately 50%.

Table 5.

R0=3.18 in (0, 72), R0=0.60 in (72, 180), R0=1.5 in (180, 300), R0=0.60 in (300, 500).

Cumulative Deaths Final Susceptible Proportion Peak death rate (Day) Peak Ward beds (Day) Peak ICU beds (Day)
63,700 90% 946 (88) 36,400 (82) 12,200 (91)

Fig. 5.

Fig. 5

The effect of early release.

11. Conclusions

The paper is motivated by a perception in the UK that the Government may have gone into lockdown too late. To guide future management and control strategies it is important to understand how the timing and relaxation of suppression might affect the total number of deaths. For example, for 26 European countries, Dye et al. (2020) plot total deaths to 20 June against number of deaths at lockdown. The UK suffered the most deaths (42,698) and had the third highest deaths (359) at lockdown (23 March).

A literature search revealed no objective assessment as to the number of lives that might have been saved in the UK by earlier intervention, and the simple model developed here is sufficient to give broad answers to this question. Rather than precise prediction, the intention has been to show the modelling principles and to demonstrate the extreme sensitivity of the total number of deaths to the timing of suppression measures and their relaxation. Literally, each day’s delay in starting suppression (lockdown) can result in thousands of extra deaths. The same is true for premature relaxation, acknowledging that the rate of decline is less than the rate of growth, so the effect although severe is not quite as strong. These conclusions are the incontrovertible consequence of the exponential growth and decline of a managed epidemic. As the UK attempts to manage the relaxation of measures from this first wave, a more sophisticated model might inform strategies that are spatially and temporally heterogeneous and combine shielding and segmentation of the population. These can then be put alongside the economic and other negative effects of prolonged suppression. The political decisions can then be well informed.

At the time of submission on 17 May, some 55 days after the lockdown of 23 March, the total deaths were 34,000 and rising, which is perhaps quite close to the scenario considered in Fig. 2. Comparing with Fig. 3 it does pose the question as to why lockdown did not occur earlier?

The finding that one week’s earlier intervention can reduce deaths by around 70% is extremely robust with respect to changes in the assumed mean latent and infectious period,4 with corresponding re-calculation of the reproduction numbers to align with the observed growth and decline rates. The absolute number of deaths will obviously be different. In this respect the conclusion as to extreme sensitivity should therefore also be quite robust with regard to the different isolation periods of hospital and non-hospitalised cases. The sensitivity obtained in this study is comparable to that obtained by Lai et al. (2020) who estimated that for China, cases might have been reduced by 66%, 86%, and 95% for one, two, and three week earlier interventions. Similarly, Li, Yang, et al. (2020) predicted for the outbreak in Hubei province in China that a 5 day delay in intervention would increase the cumulative number of cases by a factor of 2.3.

Although the primary aim of the paper has been comparison of strategies rather than prediction of absolute numbers of deaths, it is noted that the cumulative deaths obtained from the model may be an underestimate. This is because a substantial proportion of deaths occurring in care homes and community are lagging those in hospitals and were not used in the estimate of R0. Further, no account has been taken in the model of a gradual transition from the unmitigated R0 of 3.18 to the estimated value of 0.60 following lockdown. A disadvantage of using death data is that one is essentially estimating R0 some 20 days previously. But the alternative of using positive test numbers might lead to biased estimates due to the volatility of the proportion of infectious persons who are represented in such figures. This was a particular problem in the UK due to the limited test capacity, particularly in the early stages. For modelling, perhaps the compromise is to use hospital admissions as a proxy for infectious numbers.

Declaration of competing interest

I declare no conflict of interest.

Handling Editor: Yiming Shao

Footnotes

Peer review under responsibility of KeAi Communications Co., Ltd.

1

If ρ is the case fatality rate then the expected number of deaths up to time t is ρ[1S(tψ)] where ψ is an assumed constant delay between exposure and death. Differentiating, the death rate at t is ρ dS(tψ)dt=ρσR0S(tψ)I(tψ)NρσR0I(tψ) when S/N1. But ψ is random and it can be shown that a suitable approximation is death rate ρσR0I(tτ) where τ is obtained from the parameters of the delay time distribution.

2

The Government told people who showed symptoms to stay at home, without testing for seven days before contemplating hospital admission.

4

Doubling the mean exposure and infectious periods gave model deaths of 26,600 (lockdown on day 72) and 7100 (lockdown on day 65), a reduction of 73%.

References

  1. Anderson R.M., Heesterbeek H., Klinkenberg D., Hollingsworth T.D. How will country based mitigation measures influence the course of the COVID-19 epidemic ? The Lancet. 2020;395:pp931–pp934. doi: 10.1016/S0140-6736(20)30567-5. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30567-5/fulltext 21-03-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Backer J.A., Klinkenberg D., Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveillance. 2020;25(5) doi: 10.2807/1560-7917.ES.2020.25.5.2000062. 2020. pii=2000062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blackwood J.C., Childs L.M. An introduction to compartmental modeling for the budding infectious disease modeler. Letters in Biomathematics. 2018;5(1):195–221. doi: 10.1080/23737867.2018.1509026. [DOI] [Google Scholar]
  4. Davies N., Kucharski A., Eggo R., Gimma A. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: A modelling study. The Lancet Public Health. 2020;5(7):e375–e385. doi: 10.1016/S2468-2667(20)30133-X. https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30133-X/fulltext ISSN: 2468-2667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dye C., Cheng R.C.H., Dagpunar J.S., Williams B.G. 2020. The scale and dynamics of Covid-19 epidemics across Europe.https://www.medrxiv.org/content/10.1101/2020.06.26.20131144v1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferguson N.M., Laydon D., Nedjati-Gilani G. Imperial College London; 2020. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. 16-03-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flaxman S., Mishra S., Gandy A. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;2020 doi: 10.1038/s41586-020-2405-7. Published online 8 June 2020. [DOI] [PubMed] [Google Scholar]
  8. Ganyani T., Kremer C., Chen D., Torneri A., Faes C., Wallinga J., Hens N. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveillance. 2020;25(17) doi: 10.2807/1560-7917.ES.2020.25.17.2000257. 2020. pii=2000257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. He X., Lau E.H.Y., Wu P. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Medicine. 2020;26:672–675. doi: 10.1038/s41591-020-0869-5. [DOI] [PubMed] [Google Scholar]
  10. Hethcote H.W. The mathematics of infectious diseases. SIAM Review. 2000;42(4):599–653. doi: 10.1137/S0036144500371907. [DOI] [Google Scholar]
  11. Jarvis C.I., Van Zandvoort K., Gimma A. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Medicine. 2020;18:124. doi: 10.1186/s12916-020-01597-8. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lai S., Ruktanonchai N.W., Zhou L. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;(2020) doi: 10.1038/s41586-020-2293-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lauer S.A., Grantz K.H., Bi Q. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine. 2020 doi: 10.7326/M20-0504. https://www.acpjournals.org/doi/10.7326/M20-0504 Published online 5 May 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Li L., Yang Z., Dang Z., Meng C., Huang J., Meng H. Propagation analysis and prediction of the COVID-19. Infectious Disease Modelling. 2020;5:pp282–pp292. doi: 10.1016/j.idm.2020.03.002. ISSN 2468-0427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Li Q., Guan X., Wu P., Wang X. Early transmission dynamics in Wuhan, China, of Novel Corona virus infected pneumonia. New England Journal of Medicine. 2020;382(13):1199–1207. doi: 10.1056/NEJMoa2001316. https://www.nejm.org/doi/full/10.1056/NEJMoa2001316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ma J. Estimating epidemic exponential growth rate and basic reproduction number. Infectious Disease Modelling. 2020;5:129–141. doi: 10.1016/j.idm.2019.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nishiura H., Linton N.M., Akhmetzhanov A.R. Serial interval of novel coronavirus (COVID-19) infections. International Journal of Infectious Diseases. 2020;93:284–286. doi: 10.1016/j.ijid.2020.02.060. ISSN 1201-9712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zhao D., Li L., Peng H., Luo Q., Yang Y. Multiple Routes transmitted on multiplex networks. Physics Letters A. 2014;378:770–776. doi: 10.1016/j.physleta.2014.01.014. [DOI] [Google Scholar]

Articles from Infectious Disease Modelling are provided here courtesy of KeAi Publishing

RESOURCES